AMETEK stock (US0311001004): Analysts see 8.68% upside potential

AMETEK recently beat earnings expectations with EPS of $1.97. Wall Street analysts maintain a Moderate Buy rating with a $252.33 average price target, signaling upside from recent levels around $232.

AMETEK shares have drawn investor attention following a recent earnings beat, where the company reported earnings per share of $1.97, surpassing analyst expectations, according to MarketBeat as of 05/08/2026. This performance underscores the company's strong financial position in the industrials sector. The stock closed at $232.17 on May 8, 2026, on the NYSE.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: AMETEK Inc.
• Sector/industry: Industrials / Electronic Equipment
• Headquarters/country: United States
• Core markets: Aerospace, medical, industrial automation
• Key revenue drivers: Precision instruments, electromechanical devices
• Home exchange/listing venue: NYSE (AME)
• Trading currency: USD

AMETEK: core business model

AMETEK operates as a global manufacturer of electronic instruments and electromechanical devices, serving diverse end markets including aerospace, medical, and industrial applications. The company focuses on high-value, niche products that benefit from its engineering expertise and acquisition strategy. With a market capitalization around $53 billion as of recent data, AMETEK maintains a presence relevant to US investors through its NYSE listing and exposure to key domestic sectors.

Its business is divided into two main segments: Electronic Instruments (EIG) and Electromechanical (EMG). EIG provides monitoring, testing, and calibration instruments, while EMG delivers engineered components for critical applications. This dual structure allows AMETEK to capture growth in high-tech industrials, with the US market forming a core part of its revenue base.

Main revenue and product drivers for AMETEK

AMETEK generates revenue primarily from precision instruments used in power, industrial, and aerospace sectors. Key products include electronic components for aircraft, medical devices, and automation systems. The company's focus on aftermarket services and recurring revenue streams supports stable cash flows, appealing to US investors seeking industrials exposure.

In recent quarters, growth has been driven by demand in aerospace recovery and electrification trends. The earnings beat with $1.97 EPS highlights operational efficiency amid these drivers, as noted in market updates from early May 2026.

Industry trends and competitive position

The industrials sector, particularly electronic equipment, benefits from trends like aerospace modernization and automation. AMETEK holds a competitive edge through its portfolio of specialized brands and a history of accretive acquisitions, positioning it well against peers in niche markets.

Why AMETEK matters for US investors

Listed on the NYSE, AMETEK offers US investors direct access to growth in defense, medical tech, and industrial automation—sectors tied to the US economy. Its consistent performance and dividend track record make it a staple in diversified portfolios focused on American industrials.

Conclusion

AMETEK's recent earnings beat and positive analyst consensus highlight its solid footing in industrials. With a Moderate Buy rating and projected upside, the stock remains noteworthy for US investors tracking NYSE-listed names in tech-enabled manufacturing. Market dynamics will continue to shape its trajectory amid broader economic trends.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.